Advertisement
Screener

Lite Strategy, Inc. (LITS) Interest and Dividend Income, Operating

2.8 / 5 stars · 68/120 Roast Me

Lite Strategy, Inc. Interest and Dividend Income, Operating

Lite Strategy, Inc. (LITS) reported Interest and Dividend Income, Operating of $54.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:InterestAndDividendIncomeOperating · last filed 2026-05-13

  • Lite Strategy, Inc. interest and dividend income, operating for the quarter ending 2026-03-31 was $54.00K, a 73.27% decline year-over-year.
  • Lite Strategy, Inc. interest and dividend income, operating for the quarter ending 2025-12-31 was $60.00K, a 78.49% decline year-over-year.
  • Lite Strategy, Inc. interest and dividend income, operating for the quarter ending 2025-03-31 was $202.00K.
  • Lite Strategy, Inc. interest and dividend income, operating for the quarter ending 2024-12-31 was $279.00K.
Period endInterest and Dividend Income, Operating 3 monthInterest and Dividend Income, Operating 6 monthInterest and Dividend Income, Operating 9 month
2026-03-31$54.00K
10-Q · filed 2026-05-13
$114.00K
derived: sum of 2 quarters · filed 2026-05-13
$214.00K
10-Q · filed 2026-05-13
2025-12-31$60.00K
10-Q · filed 2026-02-17
$160.00K
10-Q · filed 2026-02-17
2025-03-31$202.00K
10-Q · filed 2026-05-13
$481.00K
derived: sum of 2 quarters · filed 2026-05-13
$836.00K
10-Q · filed 2026-05-13
2024-12-31$279.00K
10-Q · filed 2026-02-17
$634.00K
10-Q · filed 2026-02-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
Xilio Therapeutics, Inc. (XLO)United States$0.052B
PDS Biotechnology Corp (PDSB)United States$0.045B
SCYNEXIS INC (SCYX)United States$0.045B
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Clene Inc. (CLNN)United States$0.054B-1.99
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38